EFTA02546784.pdf

From: Jeffrey Epstein <jeevacation@gmail.com> Sent: Sunda , November 20, 2011 12:22 PM To: Subject: Re: ok On Sun, Nov 20, 2011at 7:04 AM, Georg= Church > wrote: Thanks for understanding. Probably rathe= than relaxing, I'll be spending my "spare time" in December=raising funds for PersonalGenomes.org (which includes adult human tissue c=oning & genome engineering) qp> -- George =/u> =u> <=p> From: Jeffrey =pstein <mailto:imailto:jeevacation@gmail.com]> Sent: Friday, November 18, 2011 9:59 AM I fully understand„ why don't you come=and i won't mention it. i just find it intellectually amusing,A0 marving amd martin will also be disappointed On Fri, Nov 18, 2011at 9:56 AM, George Church =1 Yes. I'm working toward this goal fairly rapidly, but =rying to do so in a way that minimizes risk to the field. James Wilson (wh= happened to be my physician, in the 1990s) set back the field of gene the=apy by a decade by rushing. http://www.scientifi=american.com/article.cfm?id=gene-therapy-an-interview chttp://www.scientificamerican.com/article=cfm?id=gene-therapy-an-interview> <=p> My lab is good at conceiving of radically new tech=ologies as well as improving throughput and quality by factors of ten. =iven a couple of years and decent funding, this would become much more rea=onable. I'm too busy doing it well to get distracted by trying to do it badl=. -- George </=> =/u> EFTA_R1_01700855 EFTA02546784 The i=formation contained in this communication is confidential, may be attorney-client privileged, may constitute inside i=formation, and is intended only for the use of the addressee. It is the=property of Jeffrey Epstein Unauthorized use, disclosure or copying=of this communication or any part thereof is strictly prohibited and may be unla=ful. If you have received this communication in error, please notify us=immediately by return e-mail or by e-mail to jeevacation@gmail.com <mailto:jeevacat=on@gmail.com> , and destroy this communication and all copies thereof, including all attachm=nts. copyright -all rights reserved 2 EFTA_R1_01700856 EFTA02546785